Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.
Also called NCT02498431
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 116 participants
- Sponsor
- 424 General Military Hospital
- Registry
-
NCT02498431
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Greece
- Registry status
- Completed
Technical summary
Registry record NCT02498431. Non-randomized; no masking; primary purpose diagnostic. Start 2015-06 (registry gives no type); primary completion 2015-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention
- Acronym
- IRICARDIO
- Condition
- Myocardial Infarction
- Condition
- Coronary Artery Disease
- Intervention (Procedure)
- percutaneous coronary intervention
- Intervention (Procedure)
- coronary angiography
- Intervention (Device)
- Stent, Medronic Resolute Integrity
- Lead sponsor
- 424 General Military Hospital
Record details
- Record id
cardio:ct-nct02498431- Content hash
74e865460b4becd3a9d0a3f0089d090ed8d34d66ab661651d6741710f01ae95a